A detailed history of Neuberger Berman Group LLC transactions in Journey Medical Corp stock. As of the latest transaction made, Neuberger Berman Group LLC holds 64,394 shares of DERM stock, worth $244,697. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,394
Previous 68,294 5.71%
Holding current value
$244,697
Previous $385,000 5.71%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.22 - $5.91 $16,458 - $23,049
-3,900 Reduced 5.71%
64,394 $363,000
Q2 2024

Nov 14, 2024

SELL
$3.31 - $5.94 $43,361 - $77,814
-13,100 Reduced 16.09%
68,294 $385,000
Q2 2024

Aug 13, 2024

SELL
$3.31 - $5.94 $43,361 - $77,814
-13,100 Reduced 16.09%
68,294 $385,000
Q1 2024

Nov 14, 2024

SELL
$2.92 - $5.47 $38,208 - $71,574
-13,085 Reduced 13.85%
81,394 $299,000
Q1 2024

May 13, 2024

BUY
$2.92 - $5.47 $237,670 - $445,225
81,394 New
81,394 $299,000
Q4 2023

Nov 14, 2024

BUY
$2.7 - $7.96 $70,699 - $208,432
26,185 Added 38.34%
94,479 $544,000
Q4 2023

Feb 09, 2024

SELL
$2.7 - $7.96 $43,402 - $127,957
-16,075 Reduced 14.54%
94,479 $544,000
Q3 2023

Nov 14, 2023

SELL
$1.66 - $2.97 $15,438 - $27,621
-9,300 Reduced 7.76%
110,554 $302,000
Q2 2023

Aug 11, 2023

SELL
$1.03 - $2.26 $9,244 - $20,283
-8,975 Reduced 6.97%
119,854 $190,000
Q1 2023

May 12, 2023

SELL
$1.28 - $2.54 $4,597 - $9,123
-3,592 Reduced 2.71%
128,829 $202,000
Q4 2022

Feb 13, 2023

SELL
$1.14 - $2.85 $33,386 - $83,465
-29,286 Reduced 18.11%
132,421 $254,000
Q3 2022

Nov 15, 2022

SELL
$2.46 - $4.15 $87,157 - $147,034
-35,430 Reduced 17.97%
161,707 $398,000
Q2 2022

Aug 15, 2022

SELL
$2.62 - $5.06 $1,310 - $2,530
-500 Reduced 0.25%
197,137 $737,000
Q1 2022

May 13, 2022

SELL
$3.93 - $5.76 $5,796 - $8,496
-1,475 Reduced 0.74%
197,637 $955,000
Q4 2021

Feb 11, 2022

BUY
$5.17 - $9.9 $1.03 Million - $1.97 Million
199,112 New
199,112 $1.07 Million

Others Institutions Holding DERM

About Journey Medical Corp


  • Ticker DERM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 11,596,500
  • Market Cap $44.1M
  • Description
  • Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...
More about DERM
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.